Drug metabolism for the perplexed medicinal chemist

Chemistry and Biodiversity

Volumn 6, Issue 11, 2009, Pages 2055-2070

  Testa, Bernard ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYTAMOXIFEN; BENZODIAZEPINE; CETIRIZINE; CLOPIDOGREL; CYTOCHROME P450; DESLORATADINE; DIAZEPAM; DRUG METABOLITE; ELECTROPHILE; FREE RADICAL; HYDROLASE; HYDROXYZINE; LORATADINE; MORPHINE 6 GLUCURONIDE; NORDAZEPAM; O NORENCAINIDE; O NORTRAMADOL; OXAZEPAM; OXIDOREDUCTASE; PARACETAMOL; PHENACETIN; PRASUGREL; PRODRUG; REACTIVE OXYGEN METABOLITE; SUXAMETHONIUM; TAMOXIFEN; TRANSFERASE; VALPROIC ACID;

CONFERENCE PAPER; DRUG DETOXIFICATION; DRUG GLUCURONIDATION; DRUG METABOLISM; DRUG STRUCTURE; DRUG TRANSFORMATION; ENZYME SUBSTRATE; FATTY LIVER; HUMAN; LIVER NECROSIS; LIVER TOXICITY; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; TERATOGENICITY; XENOBIOTIC METABOLISM;

ANIMALS; BIOTRANSFORMATION; CHEMISTRY, PHARMACEUTICAL; FORECASTING; HUMANS; PHARMACEUTICAL PREPARATIONS; PHARMACOLOGY; PRODRUGS; XENOBIOTICS;

EID: 72449122331     PISSN: 16121872     EISSN: 16121880     Source Type: Journal    
DOI: 10.1002/cbdv.200900052     Document Type: Conference Paper

References (86)

1. 'Drug Metabolism in Drug Design and Development', Eds. D. Zhang, M. Zhu, W. Griffith, Wiley-Interscience, Hoboken, 2008.
2. L. G. Yengi, L. Leung, J. Kao, Pharm. Res. 2007, 24, 842.
3. C. M. Masimirembwa, U. Bredberg, T. B. Andersson, Clin. Pharmacokinet. 2003, 42, 515.
4. B. Testa, S. D. Krämer, Chem. Biodiversity 2006, 3, 1053.
5. B. Testa, S. D. Krämer, Chem. Biodiversity 2007, 4, 257.
6. B. Testa, S. D. Krämer, Chem. Biodiversity 2007, 4, 2031.
7. B. Testa, S. D. Krämer, Chem. Biodiversity 2008, 5, 2171.
8. B. Testa, S. D. Krämer, Chem. Biodiversity 2009, 6, 591.
9. S. D. Krämer, B. Testa, Chem. Biodiversity 2008, 5, 2465.
10. S. D. Krämer, B. Testa, Chem. Biodiversity 2009, 6, 1477.
11. B. Testa, S. D. Krämer, 'The Biochemistry of Drug Metabolism: Principles, Redox Reactions, Hydrolyses', Verlag Helvetica Chimica Acta, Zürich, Wiley-VCH, Weinheim, 2008.
12. B. Testa, S. D. Krämer, 'The Biochemistry of Drug Metabolism: Conjugations, Consequences of Metabolism, Influencing Factors', Verlag Helvetica Chimica Acta, Zürich, Wiley-VCH, Weinheim, 2009, in press.
13. J. P. Uetrecht, W. F. Trager, 'Drug Metabolism - Chemical and Enzymatic Aspects', Informa Healthcare, New York, 2007.
14. B. Testa, J. M. Mayer, ' Hydrolysis in Drug and Prodrug Metabolism - Chemistry, Biochemistry, and Enzymology', Verlag Helvetica Chimica Acta, Zürich, and Wiley-VCH, Weinheim, 2003.
15. B. Testa, 'The Biochemistry of Redox Reactions', Academic Press, London, 1995.
16. B. Testa, in 'The Practice of Medicinal Chemistry', 3rd edn., Ed. C. G. Wermuth, Academic Press, London, 2008, pp. 655.
17. W. F. Trager, in 'ADME-Tox Approaches', Eds. B. Testa, H. van de Waterbeemd, Vol.5 in 'Comprehensive Medicinal Chemistry', 2nd edn., Eds. J. B. Taylor, D. J. Triggle, Elsevier, Oxford, 2007, pp. 87.
18. B. Testa, in 'ADME-Tox Approaches', Eds. B. Testa, H. van de Waterbeemd, Vol.5 in 'Comprehensive Medicinal Chemistry', 2nd edn., Eds. J. B. Taylor, D. J. Triggle, Elsevier, Oxford, 2007, pp. 133.
19. R. A. Totah, A. E. Retie, in 'ADME-Tox Approaches', Eds. B. Testa, H. van de Waterbeemd, Vol.5 in 'Comprehensive Medicinal Chemistry', 2nd edn., Eds. J. B. Taylor, D. J. Triggle, Elsevier, Oxford, 2007, pp. 167.
20. A. Fura, Y. Z. Shu, M. Zhu, R. L. Hanson, V. Roongta, W. G. Humphreys, J. Med. Chem. 2004, 47, 4339.
21. K. K. Midha, M. J. Rawson, J. W. Hubbard, Pharm. Res. 2004, 21, 1331.
22. N. Bodor, P. Buchwald, Med. Res. Rev. 2000, 20, 58.
23. N. N. Durant, R. L. Katz, Br. J. Anaesth. 1982, 54, 195.
24. B. Li, M. Sedlacek, I. Manoharan, R. Boopathy, E. G. Duysen, P. Masson, O. Lockridge, Biochem. Pharmacol. 2005, 70, 1673.
25. J. Vida, J. Yevich, in 'Burger's Medicinal Chemistry and Drug Discovery', 6th edn., Vol.6, Ed. D. J. Abraham, Wiley-Interscience, Hoboken, 2003, pp. 201.
26. D. J. Greenblatt, M. Divoli, D. R. Abernethy, H. R. Ochs, R. I. Shader, Clin. Pharmacokinet. 1983, 8, 233.
27. D. J. Greenblatt, M. Divoli, D. R. Abernethy, H. R. Ochs, R. I. Shader, Drug Metab. Rev. 1983, 14, 251.
28. D. D. Breimer, Br. J. Clin. Pharmacol. 1979, 8, 7S.
29. R. E. Favoni, A. de Cupis, Trends Pharmacol. Sci. 1998, 19, 406.
30. Z. Desta, B. A. Ward, N. V. Soukhova, D. A. Flockhart, J. Pharmacol. Exp. Ther. 2004, 310, 1062.
31. E. R. Kisanga, G. Mellgren, E. A. Lien, Anticancer Res. 2005, 25, 4487.
32. Y. C. Lim, Z. Desta, D. A. Flockhart, T. C. Skaar, Cancer Chemother. Pharmacol. 2005, 55, 471.
33. M. Farlanut, L. Franceschi, E. Pasqual, S. Bacchetti, D. Poz, G. Giorda, P. Cagol, Ther. Drug Monit. 2007, 29, 349.
34. J. N. Ingle, Cancer 2008, 112, 695.
35. A. Albert, Nature 1958, 182, 421.
36. B. Testa, in 'Drug Bioavailability - Estimation of Solubility, Permeability, Absorption and Bioavailability', 2nd edn., Eds. H. van de Waterbeemd, B. Testa, Wiley-VCH, Weinheim, 2008, pp. 559.
37. B. Testa, in 'ADME-Tox Approaches', Eds. B. Testa, H. van de Waterbeemd, Vol.5 in 'Comprehensive Medicinal Chemistry II', Eds. J. B. Taylor, D. J. Triggle, Elsevier, Oxford, 2007, pp. 1009.
38. 'Prodrugs: Challenges and Rewards, Parts 1 and 2', Eds. V. J. Stella, R. T. Borchardt, M. J. Hageman, R. Oliyai, H. Maag, J. W. Tilley, Springer, New York, 2007.
39. D. A. Smith, Curr. Opin. Drug Discovery Dev. 2007, 10, 550.
40. J. Raito, H. Kumpulainen, T. Heimbach, R. Oliyai, D. Oh, T. Järvinen, J. Savolainen, Nat. Rev. Drug Discovery 2008, 7, 255.
41. B. Testa, Biochem. Pharmacol. 2004, 68, 2097.
42. P. Ettmayer, G. Amidon, B. Clement, B. Testa, J. Med. Chem. 2004, 47, 2393.
43. P. Savi, J.-M. Pereillo, M.-F. Uzabiaga, J. Combalbert, C. Picard, J.-P. Maffrand, M. Pascal, J.-M. Herbert, Thromb. Haemostasis 2000, 84, 891.
44. J.-M. Pereillo, M. Maftouh, A. Andrieu, M.-F. Uzabiaga, O. Fedeli, P. Savi, M. Pascal, J.-M. Herbert, J.-P. Maffrand, C. Picard, Drug Metab. Dispos. 2002, 30, 1288.
45. T. A. Clarke, L. A. Waskell, Drug Metab. Dispos. 2003, 31, 53.
46. P. M. Dansette, J. Libraire, G. Bertho, D. Mansuy, Chem. Res. Toxicol. 2009, 22, 369.
47. J. A. Jakubowski, N. Matsushima, F. Asai, H. Naganuma, J. T. Brandt, T. Hirota, S. Freestone, K. J. Winters, Br. J. Clin. Pharmacol. 2006, 63, 421.
48. N. A. Farid, R. L. Smith, T. A. Gillespie, T. J. Rash, P. E. Blair, A. Kurihara, M. J. Goldberg, Drug Metab. Dispos. 2007, 35, 1096.
49. R. L. Smith, T. A. Gillespie, T. J. Rash, A. Kurihara, N. A. Farid, Xenobiotica 2007, 37, 884.
50. C. D. Payne, Y. G. Li, D. S. Small, C. S. Ernest II, N. A. Farid, J. A. Jakubowski, J. T. Brandt, D. E. Salazar, K. J. Winters, J. Cardiovasc. Pharmacol. 2007, 50, 555.
51. E. T. Williams, K. O. Jones, G. D. Ponsler, S. M. Lowery, E. J. Perkins, S. A. Wrighton, K. J. Ruterbories, M. Kazui, N. A. Farid, Drug Metab. Dispos. 2008, 36, 1227.
52. A. B. Riley, M. J. Tafreshi, S. L. Haber, Am. J. Health Syst. Pharm. 2008, 65, 1019.
53. P. D. Josephy, B. Mannervik, 'Molecular Toxicology', 2nd edn., Oxford University Press, Oxford, 2006.
54. B. Oesch-Bartlomowicz, F. Oesch, in 'ADME-Tox Approaches', Eds. B. Testa, H. van de Waterbeemd, Vol.5 in 'Comprehensive Medicinal Chemistry', 2nd edn., Eds. J. B. Taylor, D. J. Triggle, Elsevier, Oxford, 2007, pp. 193.
55. A.-C. Macherey, P. M. Dansette, in 'The Practice of Medicinal Chemistry', 3rd edn., Ed. C. G. Wermuth, Academic Press, London, 2008, pp. 674.
56. G. A. Doss, T. A. Baillie, Drug Metab. Rev. 2006, 38, 641.
57. Y.-Z. Shu, B. M. Johnson, T. J. Yang, AAPS J. 2008, 10, 178.
58. F. P. Guengerich, J. S. MacDonald, Chem. Res. Toxicol. 2007, 20, 344.
59. C. E. C. A. Hop, A. S. Kalgutkar, J. R. Soglia, Annu. Rep. Med. Chem. 2006, 41, 369.
60. G. W. Caldwell, Z. Yan, Curr. Opin. Drug Discovery Dev. 2006, 9, 47.
61. I. D. Wilson, J. K. Nicholson, in 'ADME-Tox Approaches', Eds. B. Testa, H. van de Waterbeemd, Vol.5 in 'Comprehensive Medicinal Chemistry', 2nd edn., Eds. J. B. Taylor, D. J. Triggle, Elsevier, Oxford, 2007, pp. 989.
62. T. O. Khor, S. Ibrahim, A.-N. T. Kong, Pharm. Res. 2006, 23, 1659.
63. F. P. Guengerich, AAPS J. 2006, 8, 101.
64. D. P. Williams, D. J. Naisbitt, Curr. Opin. Drug Discovery Dev. 2002, 5, 104.
65. M. Pirmohamed, B. K. Park, Trends Pharmacol. Sci. 2001, 22, 298.
66. B. K. Park, M. Pirmohamed, N. R. Kitteringham, Chem. Res. Toxicol. 1998, 11, 969.
67. K. W. Bock, Biochem. Pharmacol. 2003, 66, 691.
68. N. Masubuchi, C. Makino, N. Murayama, Chem. Res. Toxicol. 2007, 20, 455.
69. J. Kazius, R. McGuire, R. Bursi, J. Med. Chem. 2005, 48, 312.
70. A. S. Kalgutkar, I. Gardner, R. S. Obach, C. L. Shaffer, E. Callegari, K. R. Henne, A. E. Mutlib, D. K. Dalvie, J. S. Lee, Y. Nakai, J. P. O'Donnell, J. Boer, S. P. Harriman, Curr. Drug Metab. 2005, 6, 161.
71. J. Blagg, Annu. Rep. Med. Chem. 2006, 41, 353.
72. T. K. Kiang, P. C. Ho, M. R. Anari, V. Tong, F. S. Abbott, T. K. Chang, Toxicol. Sci. 2006, 94, 261.
73. A. J. M. Sadeque, M. B. Fisher, K. R. Korzekwa, F. J. Gonzalez, A. E. Rettie, J. Pharmacol. Exp. Ther. 1997, 283, 698.
74. A. E. Rettie, P. R. Sheffels, K. R. Korzekwa, F. J. Gonzalez, R. M. Philpot, T. A. Baillie, Biochemistry 1995, 34, 7889.
75. T. K. H. Chang, F. S. Abbott, Drug Metab. Rev. 2006, 38, 627.
76. M. A. Shirley, P. Hu, T. A. Baillie, Drug Metab. Dispos. 1993, 21, 580.
77. J. Li, D. L. Norwood, L.-F. Mao, H. Schulz, Biochemistry 1991, 30, 388.
78. T. A. Baillie, Chem. Res. Toxicol. 1988, 1, 195.
79. K. S. Prickett, T. A. Baillie, Drug Metab. Dispos. 1986, 14, 221.
80. W. Tang, F. S. Abbott, Chem. Res. Toxicol. 1996, 9, 517.
81. W. Tang, F. S. Abbott, Drug Metab. Dispos. 1997, 25, 219.
82. K. Kassahun, T. A. Baillie, Drug Metab. Dispos. 1993, 21, 242.
83. S. V. Gopaul, K. Farrell, F. S. Abbott, Drug Metab. Dispos. 2000, 28, 823.
84. W. Tang, A. B. Borel, F. S. Abbott, Drug Metab. Dispos. 1996, 24, 436.
85. B. Testa, P. Jenner, 'Drug Metabolism - Chemical and Biochemical Aspects', Dekker, New York, 1976.
86. 'Concepts in Drug Metabolism, Parts A and B', Eds. P. Jenner, B. Testa, Dekker, New York, 1980 and 1981.